Babraham Institute

Liston Lab

The Liston Lab works on the interface between regulatory T cells and the tissues, focussing on developing new tools to reveal novel biology.

Conflict of interests declarations

AL is an employee of the Babraham Institute and the University of Leuven, with affiliation to the VIB. The spouse of AL is an ex-employee of UCB and B&D and a current employee of Fight Bladder Cancer.

Patents and provisional patents

Inventor on EP131670416 ‘Mcl-1 as critical regulator of Foxp3+ regulatory T cell survival, and use thereof to treat severe immune disorders’.

Inventor on EP14173514.2 ‘Methods for selective cell ablation’.

Inventor on EP16195675.0 ‘Means and methods to influence the immune response’.

Paid consulting

2012, 2018, consulting for Gerson Lehrman Group.

Shares and managed funds

No financial interest in shares or managed funds since 2008. No shares ever directly held in a company in the life sciences sector.

Contract research

The laboratory has performed contract research for:

2016-2017, Complix

2016, Noxxon

2015, Complix

Contract research makes up less than 1% of the laboratory budget

The laboratory has performed collaborative industrial research for:

2017-current, Janssen

2017-2018, Novartis

All collaborative research with industry funding is entered into on the condition of full publication rights given to the laboratory, without right of publication veto given to the industrial funder

 

Last updated March 2019